卖什么
Rare Disease-Focused Care Delivery and Evidence Generation Platform
商业模式拆解
买家：谁掌握预算？
未核实Rare disease programs: pharma sponsors and hemophilia/sickle cell treatment centers (inferred; HCP dashboard and demo CTA).
工作流：什么输入变成什么输出？
Patients log in the Microhealth app (bleeding disorders, sickle cell disease, PLGD) and clinicians monitor them in real time via an HCP dashboard between visits.
经济账：省了什么，怎么收费？
Mission statement cites economic value alongside outcomes and research; commercial model not stated.
渠道：怎么接触到客户？
Book a demo; compliance (SOC 2 Type II, HIPAA, ISO 13485, CE mark) is highlighted for enterprise buyers.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2015 夏季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.